Impact of Modest Alcohol Consumption on Liver Health in NAFLD

Understanding the Liver and Fatty Liver Disease

The liver, a vital organ situated in the right upper abdomen beneath the rib cage, performs numerous essential functions. These include filtering nutrients from the blood that comes from the digestive tract, storing and releasing energy, and producing bile and clotting factors. A healthy liver can store some fat; however, when fat constitutes more than 5-10% of the liver’s weight, it is classified as “fatty liver disease.” This condition may result from excessive alcohol consumption, known as alcoholic fatty liver disease (AFLD), or can occur independently of alcohol intake, termed non-alcoholic fatty liver disease (NAFLD). The exact cause of NAFLD remains uncertain, though it may be hereditary or associated with conditions such as obesity and diabetes.

When unhealthy conditions persist, NAFLD can advance to non-alcoholic steatohepatitis (NASH), characterized by liver cell damage that leads to scarring or liver fibrosis. If the damage continues, it can result in liver cirrhosis. Initially, individuals with NAFLD may not exhibit symptoms; however, as the condition advances, they might experience fatigue, weight loss, and pain in the upper abdomen.

Can Light Alcohol Consumption Protect the Liver in NAFLD?

Currently, there is no specific treatment for NAFLD. Patients are generally advised to avoid factors that may exacerbate liver damage, maintain a healthy lifestyle, achieve a normal body weight, and ensure that any existing medical conditions, like diabetes, are well-managed. While individuals with AFLD are encouraged to abstain from alcohol, some studies suggest that moderate alcohol consumption could offer benefits for patients with NAFLD.

Recent research conducted in Japan explored the connection between alcohol intake and cellular changes in NAFLD patients. The findings were published in the journal PLoS ONE. The study involved 178 NAFLD patients recruited from Kanazawa University Hospital between 1998 and 2013. Participants were categorized into two groups based on self-reported alcohol consumption: non-drinkers (101 patients) and those consuming light alcohol (up to 20 grams of ethanol per day, consisting of 77 patients). Blood and liver biopsy samples were collected for analysis.

Results indicated that certain microscopic features of liver damage, such as “ballooning” and liver fibrosis, were significantly less pronounced in the light alcohol consumption group compared to the non-drinkers. A deeper analysis of gene expression in a subset of participants revealed that immune system pathways associated with inflammatory responses were notably reduced in the light alcohol group.

The researchers concluded that light alcohol consumption may lower gene expression levels related to immune responses, thereby decreasing liver cell damage and fibrosis. They propose that moderate alcohol intake, combined with healthy lifestyle modifications, could play a role in preventing the progression of NAFLD to NASH.

Reference

Yamada K, Mizukoshi E, Seike T, et al. Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease. PLOS ONE Jan 17, 2018. Doi: 10.1371/journal.pone.0191026.